Liver Disease Clinical Trials

A listing of Liver Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Los Angeles California

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

UPDATED

Palo Alto California

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

UPDATED

San Diego California

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

UPDATED

San Francisco California

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Florida

Tampa Florida

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Georgia

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Magnetic Resonance Imaging (MRI) for patients with Non-alcoholic Fatty Liver Disease

Hawaii

UPDATED

Honolulu Hawaii

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Maryland

UPDATED

Catonsville Maryland

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Massachusetts

UPDATED

Boston Massachusetts

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Boston Massachusetts 02115

A clinical research study of Lovaza (omega-3-acid ethyl ester) and corn oil for the treatment of Liver Disease or Short Bowel Syndrome

New York

Research Site
Additional Locations New York

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

View More ▼

UPDATED

Flushing New York

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

New York New York

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Ohio

Canton Ohio

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Cleveland Ohio 44106

Patients are needed to participate in a clinical research study evaluating Solithromycin for the treatment of Nonalcoholic Steatohepatitis without Cirrhosis

Pennsylvania

UPDATED

Philadelphia Pennsylvania

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Tennessee

ClinSearch, LLC
Chattanooga Tennessee 37421

NASH (Nonalcoholic Steatohepatitis)

Texas

View More ▼

Dallas Texas 75390-8887

Patients are needed to participate in a clinical research study of Eltrombopag to evaluate Thrombocytopenia or Hepatitis C

Utah

Salt Lake City Utah

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Canada

UPDATED

Toronto Ontario

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Italy

UPDATED

Bologna

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

UPDATED

Milano

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

UPDATED

Pisa

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Korea, Republic of

UPDATED

Daegu

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

UPDATED

Seoul

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

UPDATED

Yangsan

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

New Zealand

UPDATED

Grafton Auckland

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Taiwan

UPDATED

Kaohsiung

Patients are needed to participate in a clinical research study of TDF, GS-9620 and GS-9620 Placebo to evaluate Chronic Hepatitis B (CHB) Infection

Germany

Mainz Rhineland-Palatine

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Spain

Barcelona

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma

Turkey

Ankara

Patients are needed to participate in a clinical research study for the treatment of Cholesteryl Ester Storage Disease

United Kingdom

London

A clinical trial to evaluate treatments using BLU-554 for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma